Security key
13471N300
Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)
CUSIP: 13471N300
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 754,233
- Total 13F value
- $1,516,004
- Share change
- +126,410
- SEC-reported price per share
- $2.01
- Number of holders
- 11
- Value change
- +$242,709
- Number of buys
- 4
- Number of sells
- 3
- Shares outstanding
- 3,838,602,439
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
11
Top holders
10
CANF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Can-Fite BioPharma Ltd. SEC filings
Can-Fite BioPharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 13471N300
Recent filing periods:
Ownership snapshot
Top reported holders of CANF - Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/11
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $1,338,641
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $1.34M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$1.34M
MORGAN STANLEY
$174.9K
RHUMBLINE ADVISERS
$39.7K
HRT FINANCIAL LP
$27K
Virtu Financial LLC
$27K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$1,338,641
518,853 shares
|
— | 30 Jun 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$174,942
67,807 shares
|
— | 30 Jun 2024 |
| RHUMBLINE ADVISERS |
13F
Company
|
—
denominator unverified
|
$39,727
15,398 shares
|
— | 30 Jun 2024 |
| HRT FINANCIAL LP |
13F
Company
|
—
denominator unverified
|
$27,000
10,790 shares
|
— | 30 Jun 2024 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$27,000
10,417 shares
|
— | 30 Jun 2024 |
| FIFTH THIRD BANCORP |
13F
Company
|
—
denominator unverified
|
$7,740
3,000 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
754,233
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
13
Q3 2024 holders
11
Holder diff
-2
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend